Degarelix Prescribing at THE WILLOW GROUP
Sex hormones and hormone antagonists in malignant disease | Malignant Disease and Immunosuppression
Items (12m)
285
Total Quantity
291
NHS Cost
£34.6K
vs National Avg
+1542.1%
THE WILLOW GROUP prescribed 285 items of Degarelix over the last 12 months at a cost of £34,588 to the NHS. This is 1542.1% above the national average prescribing rate. Degarelix is classified under Sex hormones and hormone antagonists in malignant disease in the BNF.
Monthly Prescribing Trend
Jun 2026
26
Jun 2026
23
Jun 2026
25
Jun 2026
21
Jun 2026
33
Jun 2026
15
Jun 2026
24
Jun 2026
14
Jun 2026
28
Jun 2026
24
Jun 2026
27
Jun 2026
25
Prescribing Details
| Total Items | 285 |
|---|---|
| Total Quantity | 291 |
| Total NHS Cost | £34,588 |
| Presentations | 2 different forms |
| vs National Average | +1542.1% |
Degarelix Prescribing Comparison
| This practice | 285 items |
|---|---|
| National average per practice | 17 items |
| Difference | +1542.1% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.